Classic murine models of experimental asthma based on intraperitoneal sensitization followed by
airway challenge do not reflect the way in which humans acquire allergic disease to airborne allergens.
The interaction of the airway mucosa with the allergens may be essential for the triggering of the
subsequent immune response. In the present work, we developed a murine model of allergic disease based
on primary airway exposure to antigen followed by continuous airway challenge. Following sensitization
and after only three intranasal challenges, a classical intraperitoneal model developed airway
hyperresponsiveness to MCh, increased airway contractile tissue mass, eosinophilic inflammation and
mucous hypersecretion in the upper and lower airways. We detected in this model a high number of
Foxp3 mRNA+ cells in the lung inflammatory infiltrates. Conversely, murine models based on primary
airway allergen exposure and continuing challenge showed attenuated asthma features, including
borderline airway hyperresponsiveness, a modest increase in airway contractile tissue mass and mucous
production, and an attenuation of the eosinophilic inflammatory infiltrates with a drift towards a
lymphocytic profile. In such models based on primary airway exposure, mucous overproduction was
found as an early response prior to the development of any adaptive immune response, which suggests the
participation of and innate immune response prior to the onset of chronic airway inflammation.
Subepithelial collagen deposition behaved differently from the airway contractile tissue mass, and
increased progressively over time. Contrary to the intraperitoneal model, moderate numbers of Foxp3
mRNA-expressing cells were found in the pulmonary inflammatory infiltrates upon primary airway
antigen exposure. However, such Foxp3 mRNA+ cells increased over time proportionally to the duration
of the allergen instillations, and their numbers were proportionally balanced with Il10 and Tgfb mRNA
expression. These findings suggest a role of Tregs in the attenuation of the asthma features in the primary
airway exposure models, whereas most Foxp3+ cells in the intraperitoneal sensitization model may have
been non-functional. In all, these results suggest that classic animal models of experimental asthma based
on intraperitoneal sensitization represent the effector arm of the adaptive immune response, but fail to
reflect the regulatory arm, which is likely operated by Treg subpopulations. The data are also consistent
with the hypothesis that primary contact of the antigen with the respiratory mucosa is crucial to determine
the profile of the subsequent immune response in terms of attack versus tolerance, and that the innate
immune system plays a central role in such decisions.